speb/financial-data huggingface dataset:
Financial ratios for CRON — annual report dated 2025-12-31
Total revenue: 141140875.91240874
Gross profit: 45809489.05109489
Operating income: -14231386.861313868
Net income: -2137956.204379562
Capital expenditures: 18771532.846715327
Operating cash flow: 18880291.970802918
Depreciation & amortization: 10387591.240875911
Net tangible assets: 743451824.8175182
Owner earnings: -10521897.810218979
Return on net tangible assets (%): -1.4152763446107082
Buffett classification: The Gruesome
Stock price: 2.63
Shares outstanding: 373662039
Book value: 834276642.3357663
P/B ratio: 1.1779439968720664
Market cap (USD): 982731162.5699999
Debt to equity: 0.0013202573320652798
Current ratio: 19.592130657646255
Quick ratio: 18.621951978749458
COGS to revenue (%): 43.35265795421048
R&D to revenue (%): 2.30085383449781
SG&A to revenue (%): 36.62179424191805
Free cash flow (dilution-adjusted): -5284671.532846714
Buyback yield (%): 0.723516181119954
Retained earnings: 326829197.0802919
Inventory turnover: 1.7931122994652406
Receivables turnover: 3.380590230427637
Capitalized R&D asset: 6689614.835894033
ROCI (R&D-adjusted, %): -1.718561117730901
Rosenberg metric: 9.53170237480863
FCF margin (%): -3.744253037033972
Revenue growth (%): 24.725129961342777
Rule of 40 score: 20.980876924308806
Financial ratios for CYP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.37593984962406013
Shares outstanding: 243454369
Market cap (USD): 91524198.87218045
Buyback yield (%): 0.469863820763882
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYP.AX — annual report dated 2022-06-30
Operating income: -9543478.620689655
Net income: -3755291.034482759
Capital expenditures: 0
Depreciation & amortization: 193079.3103448276
Net tangible assets: 14860358.620689655
Owner earnings: -3562211.724137931
Return on net tangible assets (%): -23.971236597065467
Buffett classification: The Gruesome
Stock price: 0.2482758620689655
Shares outstanding: 243454369
Book value: 16524196.55172414
P/B ratio: 3.6578990784047716
Market cap (USD): 60443843.33793104
Debt to equity: 0
Current ratio: 9.326115248243392
Quick ratio: 9.326115248243392
Free cash flow (dilution-adjusted): -2274711.0344827585
Buyback yield (%): 0
Retained earnings: -40204352.4137931
Capitalized R&D asset: 6086133.793103448
ROCI (R&D-adjusted, %): -24.26349375832552
Rule of 40 score: 0
Financial ratios for CYP.AX — annual report dated 2023-06-30
Operating income: -10955309.27152318
Net income: -9455294.701986754
Capital expenditures: 0
Depreciation & amortization: 185407.28476821192
Net tangible assets: 9669457.61589404
Owner earnings: -9269887.417218542
Return on net tangible assets (%): -95.86770825678256
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 243454369
Book value: 11081775.49668874
P/B ratio: 1.8913618732408397
Market cap (USD): 20959647.662251655
Debt to equity: 0
Current ratio: 7.459752199390786
Quick ratio: 7.459752199390786
Free cash flow (dilution-adjusted): -9458760.927152317
Buyback yield (%): 1.0042128264290875
Retained earnings: -48062123.178807944
Capitalized R&D asset: 12285812.290385934
ROCI (R&D-adjusted, %): -32.146887268248555
Rule of 40 score: 0
Financial ratios for CYP.AX — annual report dated 2024-06-30
Operating income: -8363874.666666667
Net income: -6496472.666666667
Capital expenditures: 0
Depreciation & amortization: 187154.66666666666
Net tangible assets: 3576911.3333333335
Owner earnings: -6309318
Return on net tangible assets (%): -176.39011459980276
Buffett classification: The Gruesome
Stock price: 0.19333333333333333
Shares outstanding: 243454369
Book value: 4811490
P/B ratio: 9.782384390975214
Market cap (USD): 47067844.67333333
Debt to equity: 0
Current ratio: 5.581652441601803
Quick ratio: 5.581652441601803
Free cash flow (dilution-adjusted): -6640374
Buyback yield (%): 0
Retained earnings: -54879010
Capitalized R&D asset: 13295428.926558575
ROCI (R&D-adjusted, %): -51.19720359366483
Rule of 40 score: 0
Financial ratios for DAL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.82
Shares outstanding: 657623030
Market cap (USD): 24871302994.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAL — annual report dated 2022-12-31
Total revenue: 50582000000
Gross profit: 10597000000
Operating income: 3661000000
Net income: 1318000000
Capital expenditures: 6366000000
Operating cash flow: 6363000000
Depreciation & amortization: 2107000000
Net tangible assets: -9163000000
Owner earnings: -2941000000
Capex to operating income (%): 173.8869161431303
Buffett classification: The Gruesome
Stock price: 31.8
P/E ratio: 15.86677720333839
Shares outstanding: 657623030
Book value: 6582000000
P/B ratio: 3.1772124512306292
Market cap (USD): 20912412354
Debt to equity: 4.650562139167426
Current ratio: 0.5015805705474171
Quick ratio: 0.4466846569005397
Effective tax rate (%): 31.13897596656217
Interest coverage ratio: 3.557823129251701
COGS to revenue (%): 79.04985963386186
SG&A to revenue (%): 3.7384840457079593
Free cash flow (dilution-adjusted): -3000000
Buyback yield (%): 0
Retained earnings: 1170000000
Inventory turnover: 28.07935393258427
Receivables turnover: 15.92632241813602
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.898938465521706
FCF margin (%): -0.005930963583883594
Rule of 40 score: -0.005930963583883594
Financial ratios for DAL — annual report dated 2023-12-31
Total revenue: 58048000000
Gross profit: 14135000000
Operating income: 5521000000
Net income: 4609000000
Capital expenditures: 5323000000
Operating cash flow: 6464000000
Depreciation & amortization: 2341000000
Net tangible assets: -4631000000
Owner earnings: 1627000000
Return on net tangible assets (%): -35.13280069099547
Capex to operating income (%): 96.41369317152689
Buffett classification: The Gruesome
Stock price: 39.12
P/E ratio: 5.581734201258407
Shares outstanding: 657623030
Book value: 11105000000
P/B ratio: 2.3166333123457896
Market cap (USD): 25726212933.6
Debt to equity: 2.456641152633949
Current ratio: 0.3887122416534181
Quick ratio: 0.3389734272087213
Effective tax rate (%): 17.813837375178316
Interest coverage ratio: 6.619904076738609
COGS to revenue (%): 75.6494625137817
SG&A to revenue (%): 4.020810363836825
Free cash flow (dilution-adjusted): 1141000000
Buyback yield (%): 0
Retained earnings: 5650000000
Inventory turnover: 33.419330289193304
Receivables turnover: 18.545686900958465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.690594164231568
FCF margin (%): 1.9656146637265712
Revenue growth (%): 14.760191372424975
Rule of 40 score: 16.725806036151546
Financial ratios for DAL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.77
Shares outstanding: 657623030
Market cap (USD): 32729898203.100002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAL — annual report dated 2024-12-31
Total revenue: 61643000000
Gross profit: 15168000000
Operating income: 5995000000
Net income: 3457000000
Capital expenditures: 5140000000
Operating cash flow: 8025000000
Depreciation & amortization: 2513000000
Net tangible assets: -435000000
Owner earnings: 830000000
Return on net tangible assets (%): -190.80459770114942
Capex to operating income (%): 85.73811509591326
Buffett classification: The Gruesome
Stock price: 59.46
P/E ratio: 11.311040024240672
Shares outstanding: 657623030
Book value: 15293000000
P/B ratio: 2.5568734299221867
Market cap (USD): 39102265363.8
Debt to equity: 1.4889818871379061
Current ratio: 0.3691038620172478
Quick ratio: 0.3155605549306337
Effective tax rate (%): 25.783598110777156
Interest coverage ratio: 8.025435073627845
COGS to revenue (%): 75.39379978261927
SG&A to revenue (%): 4.031276868419772
Free cash flow (dilution-adjusted): 2885000000
Buyback yield (%): 0
Retained earnings: 8783000000
Inventory turnover: 32.54551820728291
Receivables turnover: 19.120037220843674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.309556075725842
FCF margin (%): 4.680174553477281
Revenue growth (%): 6.193150496141125
Rule of 40 score: 10.873325049618405
Financial ratios for DAL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 59.46
Shares outstanding: 657623030
Market cap (USD): 39102265363.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAL — quarterly report dated 2025-03-31
Total revenue: 14040000000
Gross profit: 2937000000
Operating income: 569000000
Net income: 240000000
Capital expenditures: 1224000000
Operating cash flow: 2378000000
Net tangible assets: -278000000
Owner earnings: -984000000
Capex to operating income (%): 215.11423550087875
Buffett classification: The Gruesome
Stock price: 42.96
P/E ratio: 29.428630592500003
Shares outstanding: 657623030
Book value: 15447000000
P/B ratio: 1.8289302368615266
Market cap (USD): 28251485368.8
Debt to equity: 1.4423512656179194
Current ratio: 0.3783292366746355
Quick ratio: 0.32829388194888715
Effective tax rate (%): 25
Interest coverage ratio: 3.17877094972067
COGS to revenue (%): 79.08119658119658
SG&A to revenue (%): 3.9316239316239314
Free cash flow (dilution-adjusted): 1154000000
Buyback yield (%): 0
Retained earnings: 8925000000
Inventory turnover: 7.471736204576043
Receivables turnover: 3.8444687842278205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1942992674684634
FCF margin (%): 8.21937321937322
Rule of 40 score: 8.21937321937322
Financial ratios for DAL — quarterly report dated 2025-06-30
Total revenue: 16648000000
Gross profit: 4607000000
Operating income: 2102000000
Net income: 2130000000
Capital expenditures: 1209000000
Operating cash flow: 1857000000
Net tangible assets: 1717000000
Owner earnings: 921000000
Return on net tangible assets (%): 53.64006988934188
Capex to operating income (%): 57.51665080875357
Buffett classification: The Good
Stock price: 48.6
P/E ratio: 13.48543428607595
Shares outstanding: 657623030
Book value: 17440000000
P/B ratio: 1.832596287729358
Market cap (USD): 31960479258
Debt to equity: 1.2201834862385321
Current ratio: 0.3846046088113749
Quick ratio: 0.33119703018841495
Effective tax rate (%): 17.24941724941725
Interest coverage ratio: 12.220930232558139
COGS to revenue (%): 72.32700624699663
SG&A to revenue (%): 4.04252763094666
Free cash flow (dilution-adjusted): 648000000
Buyback yield (%): 0
Retained earnings: 10833000000
Inventory turnover: 7.895737704918033
Receivables turnover: 4.433555259653795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.217411368150719
FCF margin (%): 3.8923594425756844
Revenue growth (%): 18.575498575498575
Rule of 40 score: 22.46785801807426
Financial ratios for DAL — quarterly report dated 2025-09-30
Total revenue: 16673000000
Gross profit: 4073000000
Operating income: 1684000000
Net income: 1417000000
Capital expenditures: 1159000000
Operating cash flow: 1847000000
Net tangible assets: 3101000000
Owner earnings: 258000000
Return on net tangible assets (%): 8.319896807481458
Capex to operating income (%): 68.82422802850357
Buffett classification: The Good
Stock price: 56.27
P/E ratio: 9.771441219461314
Shares outstanding: 657623030
Book value: 18822000000
P/B ratio: 1.9660210337955586
Market cap (USD): 37004447898.1
Debt to equity: 1.1145468069280628
Current ratio: 0.39753619597153883
Quick ratio: 0.3429147934440157
Effective tax rate (%): 20.258863252673045
Interest coverage ratio: 9.847953216374268
COGS to revenue (%): 75.57128291249326
SG&A to revenue (%): 3.868529958615726
Free cash flow (dilution-adjusted): 688000000
Buyback yield (%): 0
Retained earnings: 12126000000
Inventory turnover: 8.165910563836682
Receivables turnover: 4.616002214839424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.277922684626465
FCF margin (%): 4.126431955856774
Revenue growth (%): 0.15016818837097548
Rule of 40 score: 4.27660014422775
Financial ratios for DAL — annual report dated 2025-12-31
Total revenue: 63364000000
Gross profit: 15312000000
Operating income: 5822000000
Net income: 5005000000
Capital expenditures: 4499000000
Operating cash flow: 8342000000
Depreciation & amortization: 2443000000
Net tangible assets: 5134000000
Owner earnings: 2949000000
Return on net tangible assets (%): 57.440592130892085
Capex to operating income (%): 77.27585022329096
Buffett classification: The Gruesome
Stock price: 69.03
P/E ratio: 9.0700734787013
Shares outstanding: 657623030
Book value: 20853000000
P/B ratio: 2.1769394217091067
Market cap (USD): 45395717760.9
Debt to equity: 0.9722342109049058
Current ratio: 0.3970460469157255
Quick ratio: 0.33908919779901536
Effective tax rate (%): 19.078415521422798
Interest coverage ratio: 8.574374079528718
COGS to revenue (%): 75.83485891042233
SG&A to revenue (%): 3.921785240830756
Free cash flow (dilution-adjusted): 3843000000
Buyback yield (%): 0
Retained earnings: 13343000000
Inventory turnover: 30.01374141161774
Receivables turnover: 22.232982456140352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.8431266645559
FCF margin (%): 6.0649580203269995
Revenue growth (%): 2.7918822899599305
Rule of 40 score: 8.85684031028693
Financial ratios for DAL — quarterly report dated 2025-12-31
Total revenue: 16003000000
Gross profit: 3782000000
Operating income: 1467000000
Net income: 1219000000
Capital expenditures: 907000000
Operating cash flow: 2260000000
Net tangible assets: 5134000000
Owner earnings: 312000000
Return on net tangible assets (%): 6.077132839890923
Capex to operating income (%): 61.82685753237901
Buffett classification: The Good
Stock price: 69.03
P/E ratio: 9.068261638214143
Shares outstanding: 657623030
Book value: 20853000000
P/B ratio: 2.1769394217091067
Market cap (USD): 45395717760.9
Debt to equity: 0.9722342109049058
Current ratio: 0.3970460469157255
Quick ratio: 0.33908919779901536
Effective tax rate (%): 19.431592861863848
Interest coverage ratio: 9.284810126582279
COGS to revenue (%): 76.36693120039992
SG&A to revenue (%): 3.849278260326189
Free cash flow (dilution-adjusted): 1353000000
Buyback yield (%): 0
Retained earnings: 13343000000
Inventory turnover: 7.633354153653967
Receivables turnover: 5.615087719298246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7321997280837356
FCF margin (%): 8.454664750359306
Revenue growth (%): -4.018472980267498
Rule of 40 score: 4.436191770091808
Financial ratios for DHAMPURSUG.NS — annual report dated 2022-03-31
Total revenue: 247647369.11512595
Gross profit: 61008835.55321113
Operating income: 32336806.01345114
Net income: 18995120.6646446
Capital expenditures: 11537650.006593697
Operating cash flow: -19781.08927864961
Depreciation & amortization: 6631939.8654885935
Net tangible assets: 116431491.49413161
Owner earnings: 14089410.523539495
Return on net tangible assets (%): 12.101030694302864
Capex to operating income (%): 35.67962154887647
Buffett classification: The Good
Stock price: 6.786627983647633
P/E ratio: 22.97560311487781
Shares outstanding: 64306509
Book value: 116704470.52617699
P/B ratio: 3.7395684290620017
Market cap (USD): 436424353.5100884
Debt to equity: 1.0006779890843756
Current ratio: 1.118519783431941
Quick ratio: 0.2609665203459465
Effective tax rate (%): 28.549459271753154
Interest coverage ratio: 5.425
COGS to revenue (%): 75.36463408789558
R&D to revenue (%): 0.07348594980590124
SG&A to revenue (%): 2.4261013573600434
Free cash flow (dilution-adjusted): -11557431.095872346
Buyback yield (%): 0
Retained earnings: 107576157.1937228
Inventory turnover: 1.6577800684065032
Receivables turnover: 11.74354324307423
Capitalized R&D asset: 181986.02136357644
ROCI (R&D-adjusted, %): 21.02471234421314
FCF margin (%): -4.66689031955738
Rule of 40 score: -4.66689031955738
Financial ratios for DHAMPURSUG.NS — annual report dated 2023-03-31
Total revenue: 295717417.78319126
Gross profit: 56093788.0633374
Operating income: 31778319.12302071
Net income: 19243605.359317906
Capital expenditures: 18164433.61753959
Operating cash flow: 46638246.04141291
Depreciation & amortization: 6343483.556638246
Net tangible assets: 126771010.96224117
Owner earnings: 7422655.298416566
Return on net tangible assets (%): 5.855167709144016
Capex to operating income (%): 57.15983135300882
Buffett classification: The Good
Stock price: 2.620706455542022
P/E ratio: 8.757635594936389
Shares outstanding: 64306509
Book value: 127103532.27771012
P/B ratio: 1.325915025724471
Market cap (USD): 168528483.26967114
Debt to equity: 0.7128564857405704
Current ratio: 1.2445603076684821
Quick ratio: 0.38213354670521127
Effective tax rate (%): 29.08568607208582
Interest coverage ratio: 6.087260849276714
COGS to revenue (%): 81.03128706998814
R&D to revenue (%): 0.055193093449321204
SG&A to revenue (%): 1.32381046526954
Free cash flow (dilution-adjusted): 27333739.34226553
Buyback yield (%): 0
Retained earnings: 118925700.36540805
Inventory turnover: 2.943929009666896
Receivables turnover: 12.483109671448403
Capitalized R&D asset: 285146.2250565926
ROCI (R&D-adjusted, %): 19.367673596759623
Rosenberg metric: -27.007829793994556
FCF margin (%): 9.243195597732964
Revenue growth (%): 19.41068416750213
Rule of 40 score: 28.653879765235093
Financial ratios for DHAMPURSUG.NS — annual report dated 2024-03-31
Total revenue: 259068233.60115123
Gross profit: 54129991.605708115
Operating income: 25326777.79110205
Net income: 16131430.627173522
Capital expenditures: 6296918.0956949275
Operating cash flow: -6301714.833912939
Depreciation & amortization: 7050005.995922772
Net tangible assets: 131789183.35531838
Owner earnings: 16884518.527401365
Return on net tangible assets (%): 12.811763528330559
Capex to operating income (%): 24.862689393939394
Buffett classification: The Great
Stock price: 2.4584932821497123
P/E ratio: 9.800564130293823
Shares outstanding: 64306509
Book value: 132112963.18503419
P/B ratio: 1.1966813593725323
Market cap (USD): 158097120.375
Debt to equity: 0.8902958182428813
Current ratio: 1.2048668100679967
Quick ratio: 0.26778669222064777
Effective tax rate (%): 29.96668054977093
Interest coverage ratio: 4.7407407407407405
COGS to revenue (%): 79.10589389780455
R&D to revenue (%): 0.19579979355388194
SG&A to revenue (%): 1.3854108324037087
Free cash flow (dilution-adjusted): -15166087.060798656
Buyback yield (%): 2.275533959742949
Retained earnings: 124030459.28768438
Inventory turnover: 1.8591834292490292
Receivables turnover: 13.22216781932799
Capitalized R&D asset: 676664.8994025305
ROCI (R&D-adjusted, %): 15.42270457170771
Rosenberg metric: -12.031917102340621
FCF margin (%): -5.854089808690178
Revenue growth (%): -12.393312662059635
Rule of 40 score: -18.24740247074981
Financial ratios for DHAMPURSUG.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 129799331.10367893
Buffett classification: The Gruesome
Stock price: 2.688604873387482
Shares outstanding: 64306509
Book value: 130028666.98518872
P/B ratio: 1.3296667380865332
Market cap (USD): 172894793.487936
Debt to equity: 0.3950303141649826
Current ratio: 1.4193642771645167
Quick ratio: 0.544806490224764
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHAMPURSUG.NS — quarterly report dated 2024-12-31
Total revenue: 48011423.24280219
Gross profit: 12802191.397598786
Operating income: 2933908.3809301783
Net income: 1769436.9973190348
Capital expenditures: 0
Depreciation & amortization: 1919804.1729805337
Owner earnings: 3689241.170299568
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8554610094416597
P/E ratio: 16.858218219071144
Shares outstanding: 64306509
Market cap (USD): 119318220.10280918
Effective tax rate (%): 30.078304928604325
Interest coverage ratio: 2.4822485207100593
COGS to revenue (%): 73.33511374396076
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHAMPURSUG.NS — annual report dated 2025-03-31
Total revenue: 228725742.3427636
Gross profit: 50773906.94411971
Operating income: 12581248.538695347
Net income: 6128127.191956978
Capital expenditures: 2105447.7437456157
Operating cash flow: 23461538.46153846
Depreciation & amortization: 7238718.72808043
Net tangible assets: 134616553.65910685
Owner earnings: 11261398.176291792
Return on net tangible assets (%): 8.365537424772688
Capex to operating income (%): 16.73480765656941
Buffett classification: The Great
Stock price: 1.3783405298167815
P/E ratio: 14.46384268950237
Shares outstanding: 64306509
Book value: 134935702.59527704
P/B ratio: 0.6568778016562536
Market cap (USD): 88636267.68572763
Debt to equity: 0.8108712226226782
Current ratio: 1.2855308263512744
Quick ratio: 0.35242395683378736
Effective tax rate (%): 30.209026760750902
Interest coverage ratio: 2.1404136833731107
COGS to revenue (%): 77.80140249013556
R&D to revenue (%): 0.21313352278535358
SG&A to revenue (%): 1.3360456320405616
Free cash flow (dilution-adjusted): 21054477.43745616
Buyback yield (%): 0
Retained earnings: 127016600.42085573
Inventory turnover: 1.6894936624564365
Receivables turnover: 13.16192398250925
Capitalized R&D asset: 881213.2717089496
ROCI (R&D-adjusted, %): 7.592018378513789
Rosenberg metric: -6.616167847041545
FCF margin (%): 9.205119293439372
Revenue growth (%): -11.712162018714126
Rule of 40 score: -2.5070427252747542
Financial ratios for DHAMPURSUG.NS — quarterly report dated 2025-03-31
Total revenue: 72381342.06219313
Gross profit: 21502221.183072247
Operating income: 9560439.56043956
Net income: 5734159.457563712
Capital expenditures: 0
Depreciation & amortization: 2257423.4276361936
Net tangible assets: 134616553.65910685
Owner earnings: 7991582.885199906
Return on net tangible assets (%): 5.936552874052331
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3783405298167815
P/E ratio: 3.8643967063390123
Shares outstanding: 64306509
Book value: 134935702.59527704
P/B ratio: 0.6568778016562536
Market cap (USD): 88636267.68572763
Debt to equity: 0.8108712226226782
Current ratio: 1.2855308263512744
Quick ratio: 0.35242395683378736
Effective tax rate (%): 31.13856521128738
Interest coverage ratio: 6.849246231155779
COGS to revenue (%): 70.29314382621335
Buyback yield (%): 0
Retained earnings: 127016600.42085573
Inventory turnover: 0.483051788053009
Receivables turnover: 4.165153044063237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.753320576316975
Revenue growth (%): 50.75858446467622
Rule of 40 score: 50.75858446467622
Financial ratios for DHAMPURSUG.NS — quarterly report dated 2025-06-30
Total revenue: 61013339.574069746
Gross profit: 9778843.903580623
Operating income: 1055464.5448162884
Net income: 106482.56494266324
Capital expenditures: 0
Depreciation & amortization: 1614790.5452843437
Owner earnings: 1721273.110227007
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7765036274280366
P/E ratio: 15.011768761943104
Shares outstanding: 64306509
Market cap (USD): 114240746.50573368
Effective tax rate (%): 30.000000000000004
Interest coverage ratio: 0.5719720989220037
COGS to revenue (%): 83.97261324843697
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -15.70570835555316
Rule of 40 score: -15.70570835555316
Financial ratios for DHAMPURSUG.NS — quarterly report dated 2025-09-30
Total revenue: 56842164.59977452
Gross profit: 8213077.790304396
Operating income: -449830.89064261556
Net income: -881623.4498308906
Capital expenditures: 0
Depreciation & amortization: 1521984.2164599774
Net tangible assets: 126799323.56257045
Owner earnings: 640360.7666290868
Buffett classification: The Gruesome
Stock price: 1.4802705749718152
P/E ratio: 14.14753089495956
Shares outstanding: 64306509
Book value: 127002254.7914318
P/B ratio: 0.7495223861039849
Market cap (USD): 95191033.05186021
Debt to equity: 0.4481806641751959
Current ratio: 1.7982540968610334
Quick ratio: 1.1139280206999296
Interest coverage ratio: -0.3840230991337825
COGS to revenue (%): 85.55108193339814
Buyback yield (%): 0
Inventory turnover: 1.6474048046442349
Receivables turnover: 3.8825658401355305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2764440564527863
Revenue growth (%): -6.836496745488669
Rule of 40 score: -6.836496745488669
Financial ratios for DHAMPURSUG.NS — quarterly report dated 2025-12-31
Total revenue: 50259552.18892726
Gross profit: 14566113.400913445
Operating income: 4401247.632839479
Net income: 2956444.246407486
Capital expenditures: 0
Depreciation & amortization: 1830232.8171995098
Owner earnings: 4786677.063606996
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3552411718837027
P/E ratio: 11.010199985628452
Shares outstanding: 64306509
Market cap (USD): 87150828.61690988
Effective tax rate (%): 28.675087342112338
Interest coverage ratio: 4.686832740213523
COGS to revenue (%): 71.01821889268142
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -11.580509745178434
Rule of 40 score: -11.580509745178434
Financial ratios for DVNO.L — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0092
Shares outstanding: 26025838
Market cap (USD): 239437.7096
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DVNO.L — annual report dated 2022-11-30
Total revenue: 1244047.6190476192
Net income: 611904.7619047619
Capital expenditures: 0
Operating cash flow: 854761.9047619049
Net tangible assets: 26215476.19047619
Owner earnings: 611904.7619047619
Return on net tangible assets (%): 2.334135597838427
Buffett classification: The Gruesome
Stock price: 0.008571428571428572
P/E ratio: 0.36456426770428013
Shares outstanding: 26025838
Book value: 26215476.19047619
P/B ratio: 0.008509424349484583
Market cap (USD): 223078.61142857143
Debt to equity: 0.18164479360610328
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 50.8133971291866
Free cash flow (dilution-adjusted): 854761.9047619049
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): 68.70813397129186
Rule of 40 score: 68.70813397129186
Financial ratios for DVNO.L — annual report dated 2023-11-30
Total revenue: 916455.6962025316
Net income: 330379.746835443
Capital expenditures: 0
Operating cash flow: 1263291.1392405063
Net tangible assets: 26207594.93670886
Owner earnings: 330379.746835443
Return on net tangible assets (%): 1.2606259659969088
Buffett classification: The Gruesome
Stock price: 0.008734177215189872
P/E ratio: 0.6880393954022987
Shares outstanding: 26025838
Book value: 26207594.93670886
P/B ratio: 0.008673603274729519
Market cap (USD): 227314.28126582276
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 68.37016574585635
Free cash flow (dilution-adjusted): 1263291.1392405063
Buyback yield (%): 278.9869653848376
Capitalized R&D asset: 0
FCF margin (%): 137.84530386740332
Revenue growth (%): -26.33274786505967
Rule of 40 score: 111.51255600234364
Financial ratios for DVNO.L — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 25235443.03797468
Buffett classification: The Gruesome
Stock price: 0.008987341772151897
Shares outstanding: 26025838
Book value: 25235443.03797468
P/B ratio: 0.00926883275481541
Market cap (USD): 233903.10101265818
Debt to equity: 0.1053370786516854
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DVNO.L — annual report dated 2024-11-30
Total revenue: 1911392.405063291
Net income: 1481012.6582278481
Capital expenditures: 0
Operating cash flow: 1336708.8607594937
Net tangible assets: 25235443.03797468
Owner earnings: 1481012.6582278481
Return on net tangible assets (%): 5.868780096308187
Buffett classification: The Gruesome
Stock price: 0.008987341772151897
P/E ratio: 0.15793457247863246
Shares outstanding: 26025838
Book value: 25235443.03797468
P/B ratio: 0.00926883275481541
Market cap (USD): 233903.10101265818
Debt to equity: 0.1053370786516854
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 30.860927152317885
Free cash flow (dilution-adjusted): 1336708.8607594937
Buyback yield (%): 497.3389126540705
Capitalized R&D asset: 0
FCF margin (%): 69.93377483443709
Revenue growth (%): 108.56353591160222
Rule of 40 score: 178.49731074603932
Financial ratios for DVNO.L — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 26932432.43243243
Buffett classification: The Gruesome
Stock price: 0.009864864864864865
Shares outstanding: 26025838
Book value: 26932432.432432435
P/B ratio: 0.00953279565479177
Market cap (USD): 256741.37486486486
Debt to equity: 0.1430005017561465
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXI.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.819548872180451
Shares outstanding: 312485852
Market cap (USD): 568583279.5789473
Buyback yield (%): 0.1019550290943457
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXI.AX — annual report dated 2022-06-30
Total revenue: 51509655.172413796
Gross profit: 37135172.4137931
Operating income: 36155862.06896552
Net income: 116793103.44827586
Capital expenditures: 0
Net tangible assets: 795538620.6896552
Owner earnings: 116793103.44827586
Return on net tangible assets (%): 14.681009873163356
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4620689655172414
P/E ratio: 3.911839422733983
Shares outstanding: 312485852
Book value: 795538620.6896553
P/B ratio: 0.5742975318738724
Market cap (USD): 456875866.3724138
Debt to equity: 0.4456785296624017
Current ratio: 0.7945609812012838
Quick ratio: 0.7945609812012838
Effective tax rate (%): 2.145461479345671
Interest coverage ratio: 6.762899896800825
COGS to revenue (%): 27.906385143729327
Free cash flow (dilution-adjusted): 31850344.827586208
Buyback yield (%): 1.9532959799106873
Retained earnings: 248850344.8275862
Receivables turnover: 4.929316261879619
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.119002319053721
FCF margin (%): 61.83373723038198
Rule of 40 score: 61.83373723038198
Financial ratios for DXI.AX — annual report dated 2023-06-30
Total revenue: 52841059.602649
Gross profit: 39217880.794701986
Operating income: 38355629.13907285
Net income: 177483.44370860927
Capital expenditures: 0
Net tangible assets: 729647019.8675497
Owner earnings: 177483.44370860927
Return on net tangible assets (%): 0.024324562271333228
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.423841059602649
P/E ratio: 2506.8827679104475
Shares outstanding: 312485852
Book value: 729647019.8675497
P/B ratio: 0.609788259949699
Market cap (USD): 444930186.6225165
Debt to equity: 0.37613306624721926
Current ratio: 3.238947368421053
Quick ratio: 3.238947368421053
Interest coverage ratio: 3.8289699854555077
COGS to revenue (%): 25.78142624389021
Free cash flow (dilution-adjusted): 41020529.8013245
Buyback yield (%): 0
Retained earnings: 204681456.95364237
Receivables turnover: 17.17761033369214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.789801685999452
FCF margin (%): 77.63002882566738
Revenue growth (%): 2.5847667311666376
Rule of 40 score: 80.21479555683402
Financial ratios for DXI.AX — annual report dated 2024-06-30
Total revenue: 49637333.333333336
Gross profit: 36844666.666666664
Operating income: 35802666.666666664
Net income: -2290666.6666666665
Capital expenditures: 0
Net tangible assets: 691984666.6666666
Owner earnings: -2290666.6666666665
Return on net tangible assets (%): -0.3310285295338914
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6600000000000001
Shares outstanding: 312485852
Book value: 691984666.6666666
P/B ratio: 0.7496213995878522
Market cap (USD): 518726514.32000005
Debt to equity: 0.29172900748282476
Current ratio: 0.6204760579064588
Quick ratio: 0.6204760579064588
Interest coverage ratio: 4.842997565154657
COGS to revenue (%): 25.772268185236918
Free cash flow (dilution-adjusted): 39250000
Buyback yield (%): 0
Retained earnings: 163519333.33333334
Receivables turnover: 11.662907268170427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9789435469232166
FCF margin (%): 79.07354679273665
Revenue growth (%): -6.0629485733383355
Rule of 40 score: 73.01059821939832
Financial ratios for EOSE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.52
Shares outstanding: 354802119
Market cap (USD): 2668111934.8799996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EOSE — annual report dated 2022-12-31
Total revenue: 17924000
Gross profit: -135336000
Operating income: -214412000
Net income: -229813000
Capital expenditures: 20072000
Operating cash flow: -196857000
Depreciation & amortization: 7679000
Net tangible assets: -137282000
Owner earnings: -242206000
Buffett classification: The Gruesome
Stock price: 1.48
Shares outstanding: 354802119
Book value: -132711000
Market cap (USD): 525107136.12
Debt to equity: -1.364370700243386
Current ratio: 0.9103770470153196
Quick ratio: 0.5263965927099842
Interest coverage ratio: -11.39701270398129
COGS to revenue (%): 855.054675295693
R&D to revenue (%): 103.04061593394331
SG&A to revenue (%): 338.2224949787994
Free cash flow (dilution-adjusted): -230723000
Buyback yield (%): 0.18624770693965637
Retained earnings: -646340000
Inventory turnover: 6.588993981083405
Receivables turnover: 4.731784582893347
Capitalized R&D asset: 18469000
ROCI (R&D-adjusted, %): -312.4554866704803
FCF margin (%): -1287.229413077438
Rule of 40 score: -1287.229413077438
Financial ratios for EOSE — annual report dated 2023-12-31
Total revenue: 16378000
Gross profit: -73420000
Operating income: -145778000
Net income: -229506000
Capital expenditures: 29323000
Operating cash flow: -145018000
Depreciation & amortization: 10774000
Net tangible assets: -115426000
Owner earnings: -248055000
Buffett classification: The Gruesome
Stock price: 1.09
Shares outstanding: 354802119
Book value: -110800000
Market cap (USD): 386734309.71000004
Debt to equity: -1.8836191335740071
Current ratio: 2.00970921636274
Quick ratio: 1.729275505174963
Interest coverage ratio: -4.072693747555456
COGS to revenue (%): 548.2842837953352
R&D to revenue (%): 114.22640126999634
SG&A to revenue (%): 327.57357430699716
Free cash flow (dilution-adjusted): -188536000
Buyback yield (%): 0.16367826285561962
Retained earnings: -875846000
Inventory turnover: 5.260574106619801
Receivables turnover: 0.7977982366408495
Capitalized R&D asset: 31082230
ROCI (R&D-adjusted, %): -88.9971721461082
Rosenberg metric: 3.352428393524284
FCF margin (%): -1151.1539870558065
Revenue growth (%): -8.625306851149297
Rule of 40 score: -1159.779293906956
Financial ratios for EOSE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.97
Shares outstanding: 354802119
Market cap (USD): 1053762293.4300001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EOSE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.86
Shares outstanding: 354802119
Market cap (USD): 1724338298.3400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EOSE — annual report dated 2024-12-31
Total revenue: 15606000
Gross profit: -83261000
Operating income: -166066000
Net income: -685870000
Capital expenditures: 33152000
Operating cash flow: -153936000
Depreciation & amortization: 9132000
Net tangible assets: -1075034000
Owner earnings: -709890000
Buffett classification: The Gruesome
Stock price: 4.86
Shares outstanding: 354802119
Book value: -1070463000
Market cap (USD): 1724338298.3400002
Debt to equity: -0.2993125404614639
Current ratio: 2.7689419007310505
Quick ratio: 2.2637322046941133
Interest coverage ratio: -5.885317361874048
COGS to revenue (%): 633.519159297706
R&D to revenue (%): 145.82852748942713
SG&A to revenue (%): 384.76867871331535
Free cash flow (dilution-adjusted): -205902000
Buyback yield (%): 0.07121572380444029
Retained earnings: -1561716000
Inventory turnover: 3.011850362517517
Receivables turnover: 0.3887117664640829
Capitalized R&D asset: 41387130
ROCI (R&D-adjusted, %): -68.97572917031447
Rosenberg metric: -0.526031644216378
FCF margin (%): -1319.3771626297578
Revenue growth (%): -4.713640249114666
Rule of 40 score: -1324.0908028788724
Financial ratios for EOSE — quarterly report dated 2025-03-31
Total revenue: 10457000
Gross profit: -24539000
Operating income: -52371000
Net income: 95133000
Capital expenditures: 4918000
Operating cash flow: -28924000
Depreciation & amortization: 3053000
Net tangible assets: -946730000
Owner earnings: 93268000
Return on net tangible assets (%): -9.851594435583536
Buffett classification: The Gruesome
Stock price: 3.78
P/E ratio: 3.5244132157610926
Shares outstanding: 354802119
Book value: -942183000
Market cap (USD): 1341152009.82
Debt to equity: -0.3487655795105622
Current ratio: 2.0453277468438174
Quick ratio: 1.600815921495121
Effective tax rate (%): 0.03302291790502609
Interest coverage ratio: -7.748335552596538
COGS to revenue (%): 334.6657741225973
R&D to revenue (%): 65.38204073826145
SG&A to revenue (%): 200.7746007459118
Free cash flow (dilution-adjusted): -41416000
Buyback yield (%): 0.036386628542240784
Retained earnings: -1546580000
Inventory turnover: 0.8680639960312538
Receivables turnover: 0.4307546548030977
Capitalized R&D asset: 6837000
ROCI (R&D-adjusted, %): -26.647903023547443
FCF margin (%): -396.06005546523863
Rule of 40 score: -396.06005546523863
Financial ratios for EOSE — quarterly report dated 2025-06-30
Total revenue: 15236000
Gross profit: -30953000
Operating income: -63642000
Net income: -222937000
Capital expenditures: 7041000
Operating cash flow: -66122000
Depreciation & amortization: 3367000
Net tangible assets: -1107490000
Owner earnings: -226611000
Buffett classification: The Gruesome
Stock price: 5.12
Shares outstanding: 354802119
Book value: -1102967000
Market cap (USD): 1816586849.28
Debt to equity: -0.406488136091107
Current ratio: 2.228033994551663
Quick ratio: 1.8335283735563825
Interest coverage ratio: -13.151890886546807
COGS to revenue (%): 303.1569965870307
R&D to revenue (%): 47.263061170911
SG&A to revenue (%): 167.2880021002888
Free cash flow (dilution-adjusted): -80290000
Buyback yield (%): 0
Retained earnings: -1773973000
Inventory turnover: 1.1230548531414122
Receivables turnover: 0.6234042553191489
Capitalized R&D asset: 11781790
ROCI (R&D-adjusted, %): -22.76152355740911
Rosenberg metric: -0.9381307591048705
FCF margin (%): -526.9755841428197
Revenue growth (%): 45.701444008797935
Rule of 40 score: -481.27414013402176
Financial ratios for EOSE — quarterly report dated 2025-09-30
Total revenue: 30512000
Gross profit: -33925000
Operating income: -60636000
Net income: -641393000
Capital expenditures: 16845000
Operating cash flow: -65880000
Depreciation & amortization: 3879000
Net tangible assets: -2325775000
Owner earnings: -654359000
Buffett classification: The Gruesome
Stock price: 11.39
Shares outstanding: 354802119
Book value: -2320365000
Market cap (USD): 4041196135.4100003
Debt to equity: -0.19438579706210016
Current ratio: 1.8261201900283495
Quick ratio: 1.3660077598134548
Interest coverage ratio: -11.90575299430591
COGS to revenue (%): 211.18576297850024
R&D to revenue (%): 22.695988463555324
SG&A to revenue (%): 64.8466177241741
Free cash flow (dilution-adjusted): -88600000
Buyback yield (%): 0
Retained earnings: -2415366000
Inventory turnover: 1.3550279682045674
Receivables turnover: 1.0504355010844493
Capitalized R&D asset: 14005880
ROCI (R&D-adjusted, %): -25.411510849516116
Rosenberg metric: -0.41272045549229275
FCF margin (%): -290.3775563712637
Revenue growth (%): 100.26253609871358
Rule of 40 score: -190.11502027255014
Financial ratios for EOSE — quarterly report dated 2025-12-31
Total revenue: 10922410.55
Gross profit: -236532843.69
Operating income: -350184843.69
Net income: -120453000
Capital expenditures: 24974000
Operating cash flow: -50264000
Depreciation & amortization: 5821000
Net tangible assets: -2244172000
Owner earnings: -139606000
Buffett classification: The Gruesome
Stock price: 11.46
Shares outstanding: 354802119
Book value: -2238862000
Market cap (USD): 4066032283.7400002
Debt to equity: -0.37269291273870386
Current ratio: 4.93576703357949
Quick ratio: 4.524550647903023
Interest coverage ratio: -52.37583662728088
COGS to revenue (%): 1029.2416631418416
R&D to revenue (%): 69.38944443907576
SG&A to revenue (%): 172.49855161322424
Free cash flow (dilution-adjusted): -80451000
Buyback yield (%): 0
Retained earnings: -2535819000
Inventory turnover: 1.9045505370514688
Receivables turnover: 0.34369900091255234
Capitalized R&D asset: 14595080
ROCI (R&D-adjusted, %): -46.25981903943986
Rosenberg metric: -29.25745035234657
FCF margin (%): -736.5681745042993
Revenue growth (%): -64.20290197299423
Rule of 40 score: -800.7710764772936
Financial ratios for EOSE — annual report dated 2025-12-31
Total revenue: 21507156.31
Gross profit: -236532843.69
Operating income: -350184843.69
Net income: -969647000
Capital expenditures: 53778000
Operating cash flow: -211190000
Depreciation & amortization: 16071000
Net tangible assets: -2244172000
Owner earnings: -1007354000
Buffett classification: The Gruesome
Stock price: 11.46
Shares outstanding: 354802119
Book value: -2238862000
Market cap (USD): 4066032283.7400002
Debt to equity: -0.37269291273870386
Current ratio: 4.93576703357949
Quick ratio: 4.524550647903023
Interest coverage ratio: -15.058475325306386
COGS to revenue (%): 1199.7866955568707
R&D to revenue (%): 132.70931586027052
SG&A to revenue (%): 395.7287461589105
Free cash flow (dilution-adjusted): -290757000
Buyback yield (%): 0.012001872241681514
Retained earnings: -2535819000
Inventory turnover: 4.371632839765527
Receivables turnover: 0.6767725954246514
Capitalized R&D asset: 49963500
ROCI (R&D-adjusted, %): -43.5788163254994
Rosenberg metric: -6.734855597592055
FCF margin (%): -1351.9081547048095
Revenue growth (%): 37.813381455850305
Rule of 40 score: -1314.0947732489592
Financial ratios for EXENS.PA — annual report dated 2024-12-31
Total revenue: 487708333.3333334
Gross profit: 289062500
Operating income: 106458333.33333334
Net income: 44479166.66666667
Capital expenditures: 0
Operating cash flow: 102916666.66666667
Depreciation & amortization: 41562500
Net tangible assets: 18958333.333333336
Owner earnings: 86041666.66666667
Return on net tangible assets (%): 453.8461538461538
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.104166666666668
P/E ratio: 22.91372838407494
Shares outstanding: 50695140
Book value: 429791666.66666675
P/B ratio: 2.37134319437712
Market cap (USD): 1019183543.7500001
Debt to equity: 0.02641783809985458
Current ratio: 2.9364485981308412
Quick ratio: 2.067289719626168
Effective tax rate (%): 20.408163265306122
COGS to revenue (%): 40.730457069628365
Free cash flow (dilution-adjusted): 102916666.66666667
Buyback yield (%): 0.030661798055547734
Inventory turnover: 2.0505376344086024
Receivables turnover: 6.594366197183098
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.3943661971831
FCF margin (%): 21.10209312259718
Revenue growth (%): 50.41429790383768
Rule of 40 score: 71.51639102643486
Financial ratios for EXENS.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1076470.5882352942
Buffett classification: The Gruesome
Stock price: 47.24705882352941
Shares outstanding: 50695140
Book value: 505297647.0588235
P/B ratio: 4.7401690381673705
Market cap (USD): 2395196261.6470585
Debt to equity: 0.6197977662554162
Current ratio: 2.5145895609107156
Quick ratio: 1.666078970356064
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLCN.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 17751.49863760218
Buffett classification: The Gruesome
Stock price: 0.5669291338582677
Shares outstanding: 170080393
Market cap (USD): 96423529.88976377
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLCN.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -15074.659400544959
Operating income: -1549368.3923705723
Net income: -1599174.3869209809
Capital expenditures: 44396.185286103544
Operating cash flow: -1336307.901907357
Depreciation & amortization: 53620.98092643052
Net tangible assets: 2916950.6811989103
Owner earnings: -1589949.5912806538
Return on net tangible assets (%): -54.50724969498493
Buffett classification: The Gruesome
Stock price: 0.5
Shares outstanding: 170080393
Book value: 2916950.6811989103
P/B ratio: 29.15379990759638
Market cap (USD): 85040196.5
Debt to equity: 0.0018179934646768688
Current ratio: 12.12151704527801
Quick ratio: 12.12151704527801
Interest coverage ratio: -64.02420816772319
Free cash flow (dilution-adjusted): -1740649.863760218
Buyback yield (%): 0
Retained earnings: -10869807.356948229
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.07960612570951
Rule of 40 score: 0
Financial ratios for FLCN.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -16592.91553133515
Operating income: -1531127.5204359672
Net income: -1496135.4223433242
Capital expenditures: 11553.133514986377
Operating cash flow: -1300694.5504087193
Depreciation & amortization: 53532.42506811989
Net tangible assets: 2373311.444141689
Owner earnings: -1454156.1307901908
Return on net tangible assets (%): -61.27118859093051
Buffett classification: The Gruesome
Stock price: 0.5151515151515151
Shares outstanding: 170080393
Book value: 2373311.444141689
P/B ratio: 36.91768830752931
Market cap (USD): 87617172.15151516
Debt to equity: 0.013513465417489424
Current ratio: 14.16718638763935
Quick ratio: 14.16718638763935
Free cash flow (dilution-adjusted): -1584117.166212534
Buyback yield (%): 0
Retained earnings: -12365942.779291553
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.25007140500117
Rule of 40 score: 0
Financial ratios for FLCN.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 6928.065395095368
Buffett classification: The Gruesome
Stock price: 0.5037037037037037
Shares outstanding: 170080393
Market cap (USD): 85670123.88148147
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLCN.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 7210.08174386921
Buffett classification: The Gruesome
Stock price: 0.4195804195804196
Shares outstanding: 170080393
Market cap (USD): 71362402.65734266
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLCN.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -12155.858310626703
Operating income: -1664262.6702997275
Net income: -2146536.51226158
Capital expenditures: 0
Operating cash flow: -1375310.8991825613
Depreciation & amortization: 25314.1689373297
Net tangible assets: 939464.5776566757
Owner earnings: -2121222.3433242505
Return on net tangible assets (%): -225.7905613232652
Buffett classification: The Gruesome
Stock price: 0.4195804195804196
Shares outstanding: 170080393
Book value: 939464.5776566758
P/B ratio: 75.96071672584318
Market cap (USD): 71362402.65734266
Debt to equity: 0.028266433863569453
Current ratio: 4.945630781036772
Quick ratio: 4.945630781036772
Free cash flow (dilution-adjusted): -2076113.8964577657
Buyback yield (%): 0
Retained earnings: -14512479.291553134
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -177.15012464343565
Rule of 40 score: 0
Financial ratios for FLCN.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -3981.4713896457765
Operating income: -526336.2397820164
Net income: -587472.2070844687
Capital expenditures: 0
Operating cash flow: -389200
Depreciation & amortization: 7763.760217983651
Net tangible assets: 1603971.1171662125
Owner earnings: -579708.446866485
Return on net tangible assets (%): -36.14207516969973
Buffett classification: The Gruesome
Stock price: 0.35664335664335667
Shares outstanding: 170080393
Book value: 1603971.1171662125
P/B ratio: 37.81741554418248
Market cap (USD): 60658042.25874126
Debt to equity: 0.010938790542682382
Current ratio: 9.3932686863177
Quick ratio: 9.3932686863177
Free cash flow (dilution-adjusted): -560234.8773841962
Buyback yield (%): 0
Retained earnings: -15099951.498637602
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.81457092019909
Rule of 40 score: 0